Glenmark Life Sciences IPO
Incorporated in 2011, Glenmark Life Sciences is engaged in the production of high-value Active Pharmaceutical Ingredients (APIs). The company’s products are utilised to treat cardiovascular diseases as well as diabetes. They also cater to gastrointestinal disorders, central nervous system (CNS) therapy, along with other therapeutic areas. Presently, this company has four production facilities in Gujarat and Maharashtra. Besides manufacturing APIs, it also provides services to speciality pharmaceutical companies.
Glenmark Life Sciences IPO Objectives
- Meet its capital expenditure needs
- Fulfil its general corporate purposes
- Pay outstanding purchase consideration to the promoter for a spin-off of its Active Pharmaceutical Ingredients business.
Glenmark Life Sciences IPO - Details
On 16 July 2021, Glenmark Life Sciences filed a draft red herring prospectus with the Securities and Exchange Board of India (SEBI). Per the preliminary documents, its IPO would’ve included a fresh issue of Rs. 1,160 crores and an offer for sale of 7.3 million shares by its promoter, Glenmark Pharmaceuticals Limited.
Here are the fresh details in relation to Glenmark Life IPO that one should keep in mind:
Opening Date
Jul 27, 2021
Closing Date
Jul 29, 2021
Price Band
₹695 to ₹720
per equity share
Issue Size
₹ 1,060.00 Cr
Face Value
₹ 2
per equity share
Market Lot
20 Shares
Opening Date
Jul 27, 2021
Closing Date
Jul 29, 2021
Price Band
₹695 to ₹720
per equity share
Issue Size
₹ 1,060.00 Cr
Face Value
₹ 2
per equity share
Market Lot
20 Shares
Listing at NSE, BSE
Glenmark Life Sciences IPO Important Dates
IPO Open Date | 27 July 2021 |
---|---|
IPO Close Date | 29 July 2021 |
Basis Of Allotment Date | 03 Aug 2021 |
Initiation Of Refunds | 04 Aug 2021 |
Credit Of Shares To Demat ACcount |
05 Aug 2021 |
IPO Listing Date | 06 Aug 2021 |
UPI Mandate Expiry Date | 12 Aug 2021 |
Glenmark Life Sciences IPO Latest News and Subscription Status Today [Live]
At 05:05 p.m.
- This IPO has been subscribed 44.16x by 5.05.00 PM. on Day 3
- It is a public issue of 1,50,18,279 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 36.97x
- (NII) Non-institutional buyers: 122.54x
- (RII) Retail Individual buyers: 14.62x
At 04:10 p.m.
- This IPO has been subscribed 44.06x by 4.10.00 PM. on Day 3
- It is a public issue of 1,50,18,279 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 36.93x
- (NII) Non-institutional buyers: 122.53x
- (RII) Retail Individual buyers: 14.44x
At 03:10 p.m.
- This IPO has been subscribed 32.11x by 3.10.00 PM. on Day 3
- It is a public issue of 1,50,18,279 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 17.27x
- (NII) Non-institutional buyers: 95.54x
- (RII) Retail Individual buyers: 13.26x
At 02:20 p.m.
- This IPO has been subscribed 24.51x by 2.20.00 PM. on Day 3
- It is a public issue of 1,50,18,279 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 10.80x
- (NII) Non-institutional buyers: 69.59x
- (RII) Retail Individual buyers: 12.91x
At 01:00 p.m.
- This IPO has been subscribed 9.50x by 1.00.00 PM. on Day 3
- It is a public issue of 1,50,18,279 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 2.31x
- (NII) Non-institutional buyers: 13.58x
- (RII) Retail Individual buyers: 11.80x
At 12:45 p.m.
- This IPO has been subscribed 9.36x by 12.45:00 PM. on Day 3
- It is a public issue of 1,50,18,279 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 2.29x
- (NII) Non-institutional buyers: 13.30x
- (RII) Retail Individual buyers: 11.65x
At 11:45 a.m.
- This IPO has been subscribed 7.10x by 11.45:00 AM. on Day 3
- It is a public issue of 1,50,18,279 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 1.48x
- (NII) Non-institutional buyers: 5.78x
- (RII) Retail Individual buyers: 10.82x
At 10:45 a.m.
- This IPO has been subscribed 6.38x by 10.45:00 AM. on Day 3
- It is a public issue of 1,50,18,279 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 1.40x
- (NII) Non-institutional buyers: 4.19x
- (RII) Retail Individual buyers: 10.12x
At 05:05 p.m.
- This IPO has been subscribed 5.78x by 5.05:00 PM. on Day 2
- It is a public issue of 1,50,18,279 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 1.38x
- (NII) Non-institutional buyers: 3.39x
- (RII) Retail Individual buyers: 9.28x
At 04:05 p.m.
- This IPO has been subscribed 5.09x by 4.05:00 PM. on Day 2
- It is a public issue of 1,50,18,279 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 0.70x
- (NII) Non-institutional buyers: 2.21x
- (RII) Retail Individual buyers: 8.79x
At 03:05 p.m.
- This IPO has been subscribed 4.61x by 3.05:00 PM. on Day 2
- It is a public issue of 1,50,18,279 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 0.54x
- (NII) Non-institutional buyers: 1.89x
- (RII) Retail Individual buyers: 8.06x
At 02:05 p.m.
- This IPO has been subscribed 4.35x by 2.05:00 PM. on Day 2
- It is a public issue of 1,50,18,279 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 0.54x
- (NII) Non-institutional buyers: 1.56x
- (RII) Retail Individual buyers: 7.69x
At 01:05 p.m.
- This IPO has been subscribed 3.99x by 1.05:00 PM. on Day 2
- It is a public issue of 1,50,18,279 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 0.01x
- (NII) Non-institutional buyers: 1.41x
- (RII) Retail Individual buyers: 7.32x
At 11:45 a.m.
- This IPO has been subscribed 3.62x by 11.45:00 AM. on Day 2
- It is a public issue of 1,50,18,279 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 0.01x
- (NII) Non-institutional buyers: 1.19x
- (RII) Retail Individual buyers: 6.69x
At 10:45 a.m.
- This IPO has been subscribed 3.24x by 10.45:00 AM. on Day 2
- It is a public issue of 1,50,18,279 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: 0.01x
- (NII) Non-institutional buyers: 1.03x
- (RII) Retail Individual buyers: 6.01x
At 05:10 p.m.
- This IPO has been subscribed 2.78x by 5:10:00 PM. on Day 1
- It is a public issue of 1,50,18,279 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: xxx
- (NII) Non-institutional buyers: 0.86x
- (RII) Retail Individual buyers: 5.17x
At 04:30 p.m.
- This IPO has been subscribed 2.64x by 4:30:00 PM. on Day 1
- It is a public issue of 1,50,18,279 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: xxx
- (NII) Non-institutional buyers: 0.77x
- (RII) Retail Individual buyers: 4.93x
At 03:30 p.m.
- This IPO has been subscribed 2.46x by 3:30:00 PM. on Day 1
- It is a public issue of 1,50,18,279 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: xxx
- (NII) Non-institutional buyers: 0.71x
- (RII) Retail Individual buyers: 4.60x
At 02:05 p.m.
- This IPO has been subscribed 1.93x by 2.05:00 PM. on Day 1
- It is a public issue of 1,50,18,279 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: xxx
- (NII) Non-institutional buyers: 0.49x
- (RII) Retail Individual buyers: 3.624x
At 01:05 p.m.
- This IPO has been subscribed 1.52x by 1.05:00 PM. on Day 1
- It is a public issue of 1,50,18,279 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: xxx
- (NII) Non-institutional buyers: 0.29x
- (RII) Retail Individual buyers: 2.91x
At 11:45 a.m.
- This IPO has been subscribed 1.05x by 11.45:00 AM. on Day 1
- It is a public issue of 1,50,18,279 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: xxx
- (NII) Non-institutional buyers: 0.15x
- (RII) Retail Individual buyers: 2.02x
At 10:45 a.m.
- This IPO has been subscribed 0.51x by 10.45:00 AM. on Day 1
- It is a public issue of 1,50,18,279 equity shares.
Status of Subscription
- (QIB) Qualified institutional buyers: xxx
- (NII) Non-institutional buyers: 0.04x
- (RII) Retail Individual buyers: 0.99x
How to apply for Glenmark Life Sciences IPO?
You can apply for the Glenmark Life Sciences IPO in these ways:
UPI
Link your bank account to a reliable UPI ID and register it with your Angel One account. Proceed to book Glenmark Life Sciences IPO shares using the ID, confirm the payment on the UPI app, and block the amount for allotment.
Demat Account
1. If you are already a client of Angel One, apply directly for Glenmark Life Sciences IPO, click here.
2. If you’re a new investor Open DEMAT Account for free with Angel One to begin your investment journey.
Glenmark Life Sciences IPO - Noteworthy Highlights
Here are some key highlights regarding Glenmark Life Sciences that investors must take into account:
- The company has over 110 Active Pharmaceutical Ingredients in their catalogue.
- Glenmark Life supplies APIs to more than 500 pharmaceutical companies in India and abroad.
- They export their products to different parts of the world, including Europe, North America, and Latin America.
- As of 31 December 2020, Glenmark Life Science’s installed capacity stood at 725.8 KL.
Glenmark Life Sciences IPO - SWOT Analysis
Glenmark Life Sciences: A competitive analysis
Company name | Total income in millions (Rs.) | Return on net worth |
Glenmark Life Sciences | 15,493.03 | 77.94% |
Shilpa Medicare Limited | 9,248.49 | 11.63% |
Divis Laboratories Limited | 55,840.50 | 18.83% |
Laurus Labs Limited | 28,366.76 | 14.42% |
Solara Active Pharma Sciences Limited | 13,492.70 | 10.55% |
Aarti Drugs Limited | 18,075.71 | 21.95% |
Report from our researchers
What Is Angel One's Expert Research Report?
Our internal team of experts coalesces industry insight to prepare a thorough investigative report to give you a detailed understanding of the market. These reports are meticulously prepared to explain to you each and every step the market takes so that you always remain at the top of your investment game.